5-(3,4-difluorophenyl)-4,5-dihydroisoxazole-3-carboxylic acid, 100mg

3,3'-(Pyrazine-2,5-diyl)dipropanoic acid, 97%, 100mg

Bis(2-bromophenyl)amine, 98%, 5g

2-(4-Chlorobenzenesulfonamido)-4-methanesulfonylbutanoic acid, 97%, 100mg

5-tert-Butyl-1,3,4-oxadiazol-2-amine, 97.0%, 1g

Methyl 5-hydroxymethyl-1-methyl-1H-pyrazole-3-carboxylate, 95.0%, 1g

2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethanesulfonate potassium, 95.0%, 2.5g

2-Bromo-1-ethynyl-4-fluorobenzene, 97%, 5g

(2R,3R,4S,5R)-2-(6-((2-Hydroxyethyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95.0%, 250mg

2-(3-METHYLPHENOXY)ETHANOL, 95%, 5g

3-((Dimethylamino)methyl)-4-hydroxy-5-methoxybenzaldehyde, 97%, 5g

Transfer membrane ROTI®NC 0.45, 300 × 30 cm, 1 Piece(s)

4-Chlorobenzofuro[3,2-d]pyrimidine, 95.0%, 250mg